原发性硬化性胆管炎中胆道肠球菌定植与疾病进展相关
该研究纳入189例原发性硬化性胆管炎(PSC)患者的591份胆汁培养,在内镜逆行胰胆管造影术前未用围操作期抗生素时采样。多变量Cox回归显示,肠球菌定植(占28%)与复合临床终点风险相关,风险比3.61(95%CI 1.6-8.11;P=.002);真菌胆道定植(占19.6%)也与疾病进展相关,风险比3.25(95%CI 1.87-5.66;P<.001)。
要点
- PSC患者胆汁培养中肠球菌定植占28%,与复合临床终点风险独立相关,HR 3.61(95%CI 1.6-8.11;P=.002)。
- 真菌胆道定植占19.6%,与复合临床终点风险相关,HR 3.25(95%CI 1.87-5.66;P<.001)。
- 其他细菌种类未显示与疾病进展的独立关联。
核心结论
- 胆道肠球菌定植与PSC疾病进展存在新关联,强调微生物群-黏膜相互作用在PSC发病机制中的重要性。
- 作者认为这些结果应促进对PSC中微生物群作用的进一步机制研究,并提示潜在的新治疗靶点。
研究设计与样本
- 研究纳入189例PSC患者,共采集591份胆汁液体培养标本。
- 胆汁样本在内镜逆行胰胆管造影术前、围操作期抗生素给药前送培养。
- 排除显性细菌性胆管炎期间或既往抗生素治疗的操作。
- 主要终点定义为失代偿期肝硬化和/或肝移植或死亡的复合临床终点。
- 采用多变量Cox回归分析评估细菌定植与疾病进展的关联。
主要发现
- 肠球菌定植见于28%的患者,多变量Cox回归分析中与达到复合临床终点的风险相关,风险比3.61(95%CI 1.6-8.11;P=.002)。
- 其他细菌种类未显示与疾病进展的独立关联。
- 真菌胆道定植见于19.6%的患者,与达到复合临床终点的风险相关,风险比3.25(95%CI 1.87-5.66;P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is characterized by chronic inflammation of the biliary mucosa. Bile ducts in PSC are often colonized with bacteria. Although accumulating evidence demonstrates the importance of microbiota for mucosal immunity, little is known about the impact of bile duct colonization with bacteria on the clinical course of PSC. METHODS: Bile samples were sent to culture during endoscopic retrograde cholangio-pancreatography before the administration of peri-interventional antibiotics. Procedures during overt bacterial cholangitis or with prior antibiotic treatment were excluded. The primary endpoint was defined as a composite clinical endpoint of decompensated cirrhosis and/or liver transplantation or death. RESULTS: A cohort of 189 patients with 591 bile fluid cultures was included. In multivariable Cox regression analysis, the presence of Enterococci (present in 28% of the patients), but not of other bacterial species, conferred risk of disease progression with a hazard ratio of 3.61 (95% confidence interval, 1.6-8.11; P = .002) to reach the composite clinical endpoint. Fungobilia, present in 19.6% of patients, was confirmed to associate with disease progression with a hazard ratio of 3.25 (95% confidence interval, 1.87-5.66; P < .001) to reach the composite clinical endpoint. CONCLUSIONS: The novel association of biliary colonization by Enterococci with disease progression underlines the importance of microbiota-mucosal interplay for the pathogenesis of PSC. These results should stimulate further mechanistic studies on the role of microbiota in PSC and highlight potential new therapeutic targets for a disease without effective treatment options.
引用
- Zigmond E, Zecher BF, Bartels AL, et al. Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2022. PMID: 36116754. doi:10.1016/j.cgh.2022.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。